Pesquisar
BridgeBio Oncology Therapeutics Ord Shs
BBOTAdicionar à lista de desejos
3.990USD
-0.170-4.09%
Fechamento 09-24 16:00（ET）
319.64MValor de mercado
19.79P/L TTM
Sobre o Empresa
BridgeBio Oncology Therapeutics Ord Shs Perfil
Código da empresa- -
Nome da Empresa- -
Data de listagem- -
CEO- -
Número de funcionários- -
Tipo de títulos- -
Fim do ano fiscal- -
Endereço- -
Cidade- -
Bolsa de valores- -
País- -
Código postal- -
Telefone- -
Site- -
Código da empresa- -
Data de listagem- -
CEO- -
Executivos da empresa BridgeBio Oncology Therapeutics Ord Shs
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Pedro J. Beltran, Ph.D.
Mr. Pedro J. Beltran, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Ben (Ben) Yong, M.D.
Mr. Ben (Ben) Yong, M.D.
Chief Medical and Development Officer
Chief Medical and Development Officer
--
--
Ms. Angela Peters
Ms. Angela Peters
Senior Vice President - People
Senior Vice President - People
--
--
Mr. Wang Bin, Ph.D.
Mr. Wang Bin, Ph.D.
Senior Vice President - Drug Discovery
Senior Vice President - Drug Discovery
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Perguntas frequentes
Quem são os cinco principais acionistas de BridgeBio Oncology Therapeutics Ord Shs?
Os cinco principais acionistas de BridgeBio Oncology Therapeutics Ord Shs são: Mr. Idan Elmelech